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understand what your algorithm is of treating patients with type I
or type II endoleaks? You talked about stent graft explants, but do
the patients initially undergo embolization procedures? Do you
use Palmaz stents and/or stent graft extensions prior to explants?
Dr Eric J. Turney. Some of the procedural algorithms are
very physician-dependent. But if it is felt that improvement in
seal would be obtained by a proximal extension cuff because there
is more landing zone, Palmaz stents have been utilized. If it is sus-
pected that it is in fact a type II endoleak and if they have not been
attempted to be addressed by endovascular means prior to referral,
then we do appropriately go down those courses.Dr William Quinones-Baldrich (Los Angeles, Calif). In
2007, Dr Jimenez from our center presented our initial experience
with conversions. We thought with more endovascular aneurysm
repairs (EVARs) being performed, we were going to see more
conversions but we haven’t. With availability of fenestrated grafts
at your institution, it is surprising that you are converting so
many of these patients. So my ﬁrst question is: Why were these
patients not candidates for a fenestrated repair or a proximal exten-
sion with a fenestrated graft?
You report that many of these patients required supraceliac
clamping. Very early in our experience, we recognized that we could
actually clamp the device with the aorta and just leave portions of it,
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imally. Distally, we could use the iliac limbsmost of the times, which
really simpliﬁes the conversion. In principle, you are ﬁxing the aneu-
rysm and don’t have to explant everything. My question is: How
often did you leave components of the endovascular repair to treat
the aneurysm without a complete explantation of the endografts?
DrTurney. I will address the second question ﬁrst.Most physi-
cians, again this is a preference, chose to clamp above the device. And
it has been, for themost part, our stance that removing the endograft
in its entirety is preferential unless it becomes technically not feasible
to remove. The number of patients total that had remnant proximal
anddistalwas 22%, I believe. But in patientswhohad infection, those
were always 100% excision every time.
The ﬁrst part of the question, the patients who weren’t from
a medical comorbidity deemed to be high risk were offered open
repair. There are patients who are being converted with fenestrated
options as well. And there were multiple factors that went into it, as
well as what the patient’s wishes were and whether or not the physi-
cian felt that open conversion was the appropriate step at that time.
Dr Thomas Forbes (London, Ontario, Canada). It is
certainly a large series that we can all learn a lot about. On one
slide you touched on some of the predictive factors from the orig-
inal operation. I wonder if you could expand on that a little bit
with respect to neck length and diameter and if there were any
differences between the type of graft that was used.
Dr Turney. We didn’t ﬁnd any differences with respect to the
type of graft used. In part, it is hard to tell because the denomi-
nator is something that is uncertain as far as the grafts that areout there. We have explanted every graft that is available on the
market, and it actually seems to mirror the number of the market
share that those devices have as far as how many we are explanting.
So it does not seem that either device has shown, from our data, to
be superior or inferior.
With regards to the neck anatomy, the patients with angulated
necks at the initial time of implantation, those who didn’t obtain
a good seal and had accessory efforts placed with Palmaz stents,
and those who had angulation and short necks were the ones
who had challenging neck anatomy from the initial time of
implantation.
Dr Cassius Chaar (New Haven, Conn). In the abstract you
mentioned that the mortality for elective conversion is 9.9%
compared with 3% in your prior series. I have looked at the
open conversions after EVAR at the University of Pittsburgh
Medical Center and I reviewed the literature. Most of the elective
conversions had a mortality of less than 5%. Why do you think
there was an increase in the mortality of elective open conversion
in the second group?
Dr Turney. Actually that was one of the things that initially
caught our eye when we were looking through the data, and we
expected that the comorbidity presence was going to be higher
in the patients who were in the newer group, but in fact, there
was no statistically signiﬁcant difference, and the difference in
mortality didn’t reach statistical signiﬁcance. We don’t know if it
is because we are being a little more willing to offer open conver-
sion to patients who are higher risk and it is just something that
hasn’t been borne out in the statistics yet.
